Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 50

1.

Sleeping beauty genetic screen identifies miR-23b::BTBD7 gene interaction as crucial for colorectal cancer metastasis.

Grisard E, Coan M, Cesaratto L, Rigo I, Zandonà L, Paulitti A, Andreuzzi E, Rampioni Vinciguerra GL, Poletto E, Del Ben F, Brisotto G, Biscontin E, Turetta M, Dassi E, Mirnezami A, Canzonieri V, Vecchione A, Baldassarre G, Mongiat M, Spizzo R, Nicoloso MS.

EBioMedicine. 2019 Aug;46:79-93. doi: 10.1016/j.ebiom.2019.06.044. Epub 2019 Jul 11.

2.

USP1 links platinum resistance to cancer cell dissemination by regulating Snail stability.

Sonego M, Pellarin I, Costa A, Vinciguerra GLR, Coan M, Kraut A, D'Andrea S, Dall'Acqua A, Castillo-Tong DC, Califano D, Losito S, Spizzo R, Couté Y, Vecchione A, Belletti B, Schiappacassi M, Baldassarre G.

Sci Adv. 2019 May 8;5(5):eaav3235. doi: 10.1126/sciadv.aav3235. eCollection 2019 May.

3.

Correction: CpG island hypermethylation-associated silencing of non-coding RNAs transcribed from ultraconserved regions in human cancer.

Lujambio A, Portela A, Liz J, Melo SA, Rossi S, Spizzo R, Croce CM, Calin GA, Esteller M.

Oncogene. 2019 Jan;38(5):765-766. doi: 10.1038/s41388-018-0560-1.

PMID:
30397238
4.

Mutant p53 blocks SESN1/AMPK/PGC-1α/UCP2 axis increasing mitochondrial O2-· production in cancer cells.

Cordani M, Butera G, Dando I, Torrens-Mas M, Butturini E, Pacchiana R, Oppici E, Cavallini C, Gasperini S, Tamassia N, Nadal-Serrano M, Coan M, Rossi D, Gaidano G, Caraglia M, Mariotto S, Spizzo R, Roca P, Oliver J, Scupoli MT, Donadelli M.

Br J Cancer. 2018 Oct;119(8):994-1008. doi: 10.1038/s41416-018-0288-2. Epub 2018 Oct 15.

5.

Exploring the Role of Fallopian Ciliated Cells in the Pathogenesis of High-Grade Serous Ovarian Cancer.

Coan M, Rampioni Vinciguerra GL, Cesaratto L, Gardenal E, Bianchet R, Dassi E, Vecchione A, Baldassarre G, Spizzo R, Nicoloso MS.

Int J Mol Sci. 2018 Aug 24;19(9). pii: E2512. doi: 10.3390/ijms19092512. Review.

6.

N-BLR, a primate-specific non-coding transcript leads to colorectal cancer invasion and migration.

Rigoutsos I, Lee SK, Nam SY, Anfossi S, Pasculli B, Pichler M, Jing Y, Rodriguez-Aguayo C, Telonis AG, Rossi S, Ivan C, Catela Ivkovic T, Fabris L, Clark PM, Ling H, Shimizu M, Redis RS, Shah MY, Zhang X, Okugawa Y, Jung EJ, Tsirigos A, Huang L, Ferdin J, Gafà R, Spizzo R, Nicoloso MS, Paranjape AN, Shariati M, Tiron A, Yeh JJ, Teruel-Montoya R, Xiao L, Melo SA, Menter D, Jiang ZQ, Flores ER, Negrini M, Goel A, Bar-Eli M, Mani SA, Liu CG, Lopez-Berestein G, Berindan-Neagoe I, Esteller M, Kopetz S, Lanza G, Calin GA.

Genome Biol. 2017 May 24;18(1):98. doi: 10.1186/s13059-017-1224-0.

7.

BNC2 is a putative tumor suppressor gene in high-grade serous ovarian carcinoma and impacts cell survival after oxidative stress.

Cesaratto L, Grisard E, Coan M, Zandonà L, De Mattia E, Poletto E, Cecchin E, Puglisi F, Canzonieri V, Mucignat MT, Zucchetto A, Stocco G, Colombatti A, Nicoloso MS, Spizzo R.

Cell Death Dis. 2016 Dec 22;7(12):e2526. doi: 10.1038/cddis.2016.448. No abstract available.

8.

BNC2 is a putative tumor suppressor gene in high-grade serous ovarian carcinoma and impacts cell survival after oxidative stress.

Cesaratto L, Grisard E, Coan M, Zandonà L, De Mattia E, Poletto E, Cecchin E, Puglisi F, Canzonieri V, Mucignat MT, Zucchetto A, Stocco G, Colombatti A, Nicoloso MS, Spizzo R.

Cell Death Dis. 2016 Sep 22;7(9):e2374. doi: 10.1038/cddis.2016.278. Erratum in: Cell Death Dis. 2016 Dec 22;7(12 ):e2526.

9.

Over-expression of the miR-483-3p overcomes the miR-145/TP53 pro-apoptotic loop in hepatocellular carcinoma.

Lupini L, Pepe F, Ferracin M, Braconi C, Callegari E, Pagotto S, Spizzo R, Zagatti B, Lanuti P, Fornari F, Ghasemi R, Mariani-Costantini R, Bolondi L, Gramantieri L, Calin GA, Sabbioni S, Visone R, Veronese A, Negrini M.

Oncotarget. 2016 May 24;7(21):31361-71. doi: 10.18632/oncotarget.8913.

10.

Thiopurine Biotransformation and Pharmacological Effects: Contribution of Oxidative Stress.

Pelin M, De Iudicibus S, Londero M, Spizzo R, Dei Rossi S, Martelossi S, Ventura A, Decorti G, Stocco G.

Curr Drug Metab. 2016;17(6):542-9. Review.

PMID:
26935390
11.

SERS analysis of serum for detection of early and locally advanced breast cancer.

Cervo S, Mansutti E, Del Mistro G, Spizzo R, Colombatti A, Steffan A, Sergo V, Bonifacio A.

Anal Bioanal Chem. 2015 Sep;407(24):7503-9. doi: 10.1007/s00216-015-8923-8. Epub 2015 Aug 9.

PMID:
26255294
12.

The clinical and biological significance of MIR-224 expression in colorectal cancer metastasis.

Ling H, Pickard K, Ivan C, Isella C, Ikuo M, Mitter R, Spizzo R, Bullock M, Braicu C, Pileczki V, Vincent K, Pichler M, Stiegelbauer V, Hoefler G, Almeida MI, Hsiao A, Zhang X, Primrose J, Packham G, Liu K, Bojja K, Gafà R, Xiao L, Rossi S, Song JH, Vannini I, Fanini F, Kopetz S, Zweidler-McKay P, Wang X, Ionescu C, Irimie A, Fabbri M, Lanza G, Hamilton SR, Berindan-Neagoe I, Medico E, Mirnezami A, Calin GA, Nicoloso MS.

Gut. 2016 Jun;65(6):977-989. doi: 10.1136/gutjnl-2015-309372. Epub 2015 Mar 24.

13.

Surface-enhanced Raman spectroscopy of urine for prostate cancer detection: a preliminary study.

Del Mistro G, Cervo S, Mansutti E, Spizzo R, Colombatti A, Belmonte P, Zucconelli R, Steffan A, Sergo V, Bonifacio A.

Anal Bioanal Chem. 2015 May;407(12):3271-5. doi: 10.1007/s00216-015-8610-9. Epub 2015 Mar 20.

PMID:
25791298
14.

Surface-enhanced Raman spectroscopy of blood plasma and serum using Ag and Au nanoparticles: a systematic study.

Bonifacio A, Dalla Marta S, Spizzo R, Cervo S, Steffan A, Colombatti A, Sergo V.

Anal Bioanal Chem. 2014 Apr;406(9-10):2355-65. doi: 10.1007/s00216-014-7622-1. Epub 2014 Feb 4.

PMID:
24493335
15.

Fhit delocalizes annexin a4 from plasma membrane to cytosol and sensitizes lung cancer cells to paclitaxel.

Gaudio E, Paduano F, Spizzo R, Ngankeu A, Zanesi N, Gaspari M, Ortuso F, Lovat F, Rock J, Hill GA, Kaou M, Cuda G, Aqeilan RI, Alcaro S, Croce CM, Trapasso F.

PLoS One. 2013 Nov 6;8(11):e78610. doi: 10.1371/journal.pone.0078610. eCollection 2013.

16.

miR-203 induces oxaliplatin resistance in colorectal cancer cells by negatively regulating ATM kinase.

Zhou Y, Wan G, Spizzo R, Ivan C, Mathur R, Hu X, Ye X, Lu J, Fan F, Xia L, Calin GA, Ellis LM, Lu X.

Mol Oncol. 2014 Feb;8(1):83-92. doi: 10.1016/j.molonc.2013.09.004. Epub 2013 Oct 8.

17.

CCAT2, a novel long non-coding RNA in breast cancer: expression study and clinical correlations.

Redis RS, Sieuwerts AM, Look MP, Tudoran O, Ivan C, Spizzo R, Zhang X, de Weerd V, Shimizu M, Ling H, Buiga R, Pop V, Irimie A, Fodde R, Bedrosian I, Martens JW, Foekens JA, Berindan-Neagoe I, Calin GA.

Oncotarget. 2013 Oct;4(10):1748-62.

18.

Therapeutic synergy between microRNA and siRNA in ovarian cancer treatment.

Nishimura M, Jung EJ, Shah MY, Lu C, Spizzo R, Shimizu M, Han HD, Ivan C, Rossi S, Zhang X, Nicoloso MS, Wu SY, Almeida MI, Bottsford-Miller J, Pecot CV, Zand B, Matsuo K, Shahzad MM, Jennings NB, Rodriguez-Aguayo C, Lopez-Berestein G, Sood AK, Calin GA.

Cancer Discov. 2013 Nov;3(11):1302-15. doi: 10.1158/2159-8290.CD-13-0159. Epub 2013 Sep 3.

19.

CCAT2, a novel noncoding RNA mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancer.

Ling H, Spizzo R, Atlasi Y, Nicoloso M, Shimizu M, Redis RS, Nishida N, Gafà R, Song J, Guo Z, Ivan C, Barbarotto E, De Vries I, Zhang X, Ferracin M, Churchman M, van Galen JF, Beverloo BH, Shariati M, Haderk F, Estecio MR, Garcia-Manero G, Patijn GA, Gotley DC, Bhardwaj V, Shureiqi I, Sen S, Multani AS, Welsh J, Yamamoto K, Taniguchi I, Song MA, Gallinger S, Casey G, Thibodeau SN, Le Marchand L, Tiirikainen M, Mani SA, Zhang W, Davuluri RV, Mimori K, Mori M, Sieuwerts AM, Martens JW, Tomlinson I, Negrini M, Berindan-Neagoe I, Foekens JA, Hamilton SR, Lanza G, Kopetz S, Fodde R, Calin GA.

Genome Res. 2013 Sep;23(9):1446-61. doi: 10.1101/gr.152942.112. Epub 2013 Jun 24.

20.

Expression of thymidine phosphorylase and cyclooxygenase-2 in melanoma.

Minisini AM, Pascoletti G, Intersimone D, Poletto E, Driol P, Spizzo R, Scott CA, Puglisi F, Fasola G, Di Loreto C.

Melanoma Res. 2013 Apr;23(2):96-101. doi: 10.1097/CMR.0b013e32835e7734.

PMID:
23411479
21.

Modulation of MicroRNA-194 and cell migration by HER2-targeting trastuzumab in breast cancer.

Le XF, Almeida MI, Mao W, Spizzo R, Rossi S, Nicoloso MS, Zhang S, Wu Y, Calin GA, Bast RC Jr.

PLoS One. 2012;7(7):e41170. doi: 10.1371/journal.pone.0041170. Epub 2012 Jul 19.

22.

Long non-coding RNAs and cancer: a new frontier of translational research?

Spizzo R, Almeida MI, Colombatti A, Calin GA.

Oncogene. 2012 Oct 25;31(43):4577-87. doi: 10.1038/onc.2011.621. Epub 2012 Jan 23. Review.

23.

Strand-specific miR-28-5p and miR-28-3p have distinct effects in colorectal cancer cells.

Almeida MI, Nicoloso MS, Zeng L, Ivan C, Spizzo R, Gafà R, Xiao L, Zhang X, Vannini I, Fanini F, Fabbri M, Lanza G, Reis RM, Zweidler-McKay PA, Calin GA.

Gastroenterology. 2012 Apr;142(4):886-896.e9. doi: 10.1053/j.gastro.2011.12.047. Epub 2012 Jan 10.

24.

Tcl1 interacts with Atm and enhances NF-κB activation in hematologic malignancies.

Gaudio E, Spizzo R, Paduano F, Luo Z, Efanov A, Palamarchuk A, Leber AS, Kaou M, Zanesi N, Bottoni A, Costinean S, Rassenti LZ, Nakamura T, Kipps TJ, Aqeilan RI, Pekarsky Y, Trapasso F, Croce CM.

Blood. 2012 Jan 5;119(1):180-7. doi: 10.1182/blood-2011-08-374561. Epub 2011 Nov 7.

25.

Small molecule enoxacin is a cancer-specific growth inhibitor that acts by enhancing TAR RNA-binding protein 2-mediated microRNA processing.

Melo S, Villanueva A, Moutinho C, Davalos V, Spizzo R, Ivan C, Rossi S, Setien F, Casanovas O, Simo-Riudalbas L, Carmona J, Carrere J, Vidal A, Aytes A, Puertas S, Ropero S, Kalluri R, Croce CM, Calin GA, Esteller M.

Proc Natl Acad Sci U S A. 2011 Mar 15;108(11):4394-9. doi: 10.1073/pnas.1014720108. Epub 2011 Feb 28. Erratum in: Proc Natl Acad Sci U S A. 2017 Jan 17;:.

26.

Association of a microRNA/TP53 feedback circuitry with pathogenesis and outcome of B-cell chronic lymphocytic leukemia.

Fabbri M, Bottoni A, Shimizu M, Spizzo R, Nicoloso MS, Rossi S, Barbarotto E, Cimmino A, Adair B, Wojcik SE, Valeri N, Calore F, Sampath D, Fanini F, Vannini I, Musuraca G, Dell'Aquila M, Alder H, Davuluri RV, Rassenti LZ, Negrini M, Nakamura T, Amadori D, Kay NE, Rai KR, Keating MJ, Kipps TJ, Calin GA, Croce CM.

JAMA. 2011 Jan 5;305(1):59-67. doi: 10.1001/jama.2010.1919.

27.

A genetic defect in exportin-5 traps precursor microRNAs in the nucleus of cancer cells.

Melo SA, Moutinho C, Ropero S, Calin GA, Rossi S, Spizzo R, Fernandez AF, Davalos V, Villanueva A, Montoya G, Yamamoto H, Schwartz S Jr, Esteller M.

Cancer Cell. 2010 Oct 19;18(4):303-15. doi: 10.1016/j.ccr.2010.09.007.

28.

High-throughput profiling in the hematopoietic system.

Fabbri M, Spizzo R, Calin GA.

Methods Mol Biol. 2010;667:79-91. doi: 10.1007/978-1-60761-811-9_6.

PMID:
20827528
29.

CpG island hypermethylation-associated silencing of non-coding RNAs transcribed from ultraconserved regions in human cancer.

Lujambio A, Portela A, Liz J, Melo SA, Rossi S, Spizzo R, Croce CM, Calin GA, Esteller M.

Oncogene. 2010 Dec 2;29(48):6390-401. doi: 10.1038/onc.2010.361. Epub 2010 Aug 30. Erratum in: Oncogene. 2019 Jan;38(5):765-766.

30.

Prognostic stratification of stage IIIA pN2 non-small cell lung cancer by hierarchical clustering analysis of tissue microarray immunostaining data: an Alpe Adria Thoracic Oncology Multidisciplinary Group study (ATOM 014).

Grossi F, Spizzo R, Bordo D, Cacitti V, Valent F, Rossetto C, Follador A, Di Terlizzi S, Aita M, Morelli A, Fasola G, Consiglieri C, Ceschia T, Beltrami CA, Belvedere O.

J Thorac Oncol. 2010 Sep;5(9):1354-60. doi: 10.1097/JTO.0b013e3181e77a78.

31.

Single-nucleotide polymorphisms inside microRNA target sites influence tumor susceptibility.

Nicoloso MS, Sun H, Spizzo R, Kim H, Wickramasinghe P, Shimizu M, Wojcik SE, Ferdin J, Kunej T, Xiao L, Manoukian S, Secreto G, Ravagnani F, Wang X, Radice P, Croce CM, Davuluri RV, Calin GA.

Cancer Res. 2010 Apr 1;70(7):2789-98. doi: 10.1158/0008-5472.CAN-09-3541. Epub 2010 Mar 23.

32.

miR-328 functions as an RNA decoy to modulate hnRNP E2 regulation of mRNA translation in leukemic blasts.

Eiring AM, Harb JG, Neviani P, Garton C, Oaks JJ, Spizzo R, Liu S, Schwind S, Santhanam R, Hickey CJ, Becker H, Chandler JC, Andino R, Cortes J, Hokland P, Huettner CS, Bhatia R, Roy DC, Liebhaber SA, Caligiuri MA, Marcucci G, Garzon R, Croce CM, Calin GA, Perrotti D.

Cell. 2010 Mar 5;140(5):652-65. doi: 10.1016/j.cell.2010.01.007.

33.

RNA inhibition, microRNAs, and new therapeutic agents for cancer treatment.

Spizzo R, Rushworth D, Guerrero M, Calin GA.

Clin Lymphoma Myeloma. 2009;9 Suppl 3:S313-8. doi: 10.3816/CLM.2009.s.030. Review.

PMID:
19778859
34.

miR-145 participates with TP53 in a death-promoting regulatory loop and targets estrogen receptor-alpha in human breast cancer cells.

Spizzo R, Nicoloso MS, Lupini L, Lu Y, Fogarty J, Rossi S, Zagatti B, Fabbri M, Veronese A, Liu X, Davuluri R, Croce CM, Mills G, Negrini M, Calin GA.

Cell Death Differ. 2010 Feb;17(2):246-54. doi: 10.1038/cdd.2009.117. Epub 2009 Sep 4.

35.

Multiple approach to analyzing the role of microRNAs in apoptosis.

Spizzo R, Calin GA.

Methods Mol Biol. 2009;559:219-45. doi: 10.1007/978-1-60327-017-5_16.

PMID:
19609760
36.

SnapShot: MicroRNAs in Cancer.

Spizzo R, Nicoloso MS, Croce CM, Calin GA.

Cell. 2009 May 1;137(3):586-586.e1. doi: 10.1016/j.cell.2009.04.040. No abstract available.

37.

MicroRNAs--the micro steering wheel of tumour metastases.

Nicoloso MS, Spizzo R, Shimizu M, Rossi S, Calin GA.

Nat Rev Cancer. 2009 Apr;9(4):293-302. doi: 10.1038/nrc2619. Epub 2009 Mar 5. Review.

PMID:
19262572
38.

MicroRNAs as new biomarkers in oncology.

Spizzo R, Nicoloso MS, Calin GA.

Expert Opin Med Diagn. 2008 Feb;2(2):115-27. doi: 10.1517/17530059.2.2.115.

PMID:
23485132
39.

Expression profiling of microRNA using oligo DNA arrays.

Liu CG, Spizzo R, Calin GA, Croce CM.

Methods. 2008 Jan;44(1):22-30. Review.

40.

Ultraconserved regions encoding ncRNAs are altered in human leukemias and carcinomas.

Calin GA, Liu CG, Ferracin M, Hyslop T, Spizzo R, Sevignani C, Fabbri M, Cimmino A, Lee EJ, Wojcik SE, Shimizu M, Tili E, Rossi S, Taccioli C, Pichiorri F, Liu X, Zupo S, Herlea V, Gramantieri L, Lanza G, Alder H, Rassenti L, Volinia S, Schmittgen TD, Kipps TJ, Negrini M, Croce CM.

Cancer Cell. 2007 Sep;12(3):215-29.

41.

mRNA/microRNA gene expression profile in microsatellite unstable colorectal cancer.

Lanza G, Ferracin M, Gafà R, Veronese A, Spizzo R, Pichiorri F, Liu CG, Calin GA, Croce CM, Negrini M.

Mol Cancer. 2007 Aug 23;6:54.

42.

Use of miRNA expression profiling to identify novel biomarkers.

Sever NI, Younan S, E Wojcik S, Spizzo R, Fabbri M, Calin GA.

Per Med. 2007 May;4(2):147-155. doi: 10.2217/17410541.4.2.147.

PMID:
29788626
43.

Anticancer activity of an adenoviral vector expressing short hairpin RNA against BK virus T-ag.

Sabbioni S, Callegari E, Spizzo R, Veronese A, Altavilla G, Corallini A, Negrini M.

Cancer Gene Ther. 2007 Mar;14(3):297-305. Epub 2007 Jan 12.

PMID:
17218949
44.

Phase II study of irinotecan and docetaxel in patients with previously treated non-small cell lung cancer: an Alpe-Adria Thoracic Oncology Multidisciplinary group study (ATOM 007).

Grossi F, Fasola G, Rossetto C, Spizzo R, Meduri S, Sibau A, Vigevani E, Tumolo S, Adami G, Sacco C, Recchia L, Rizzato S, Ceschia T, Belvedere O.

Lung Cancer. 2006 Apr;52(1):89-92. Epub 2006 Feb 17.

PMID:
16483688
45.

MicroRNA gene expression deregulation in human breast cancer.

Iorio MV, Ferracin M, Liu CG, Veronese A, Spizzo R, Sabbioni S, Magri E, Pedriali M, Fabbri M, Campiglio M, Ménard S, Palazzo JP, Rosenberg A, Musiani P, Volinia S, Nenci I, Calin GA, Querzoli P, Negrini M, Croce CM.

Cancer Res. 2005 Aug 15;65(16):7065-70.

46.

Association between plasminogen activator inhibitor 1 gene polymorphisms and preeclampsia.

Fabbro D, D'Elia AV, Spizzo R, Driul L, Barillari G, Di Loreto C, Marchesoni D, Damante G.

Gynecol Obstet Invest. 2003;56(1):17-22. Epub 2003 Jul 14.

PMID:
12867763
47.

A case report of Sertoli cell tumor in a patient with testicular feminization: many dilemmas for the pathologist.

Spizzo R, Intersimone D, Artico D, Driul L, Di Loreto C, Beltrami CA.

Adv Clin Path. 2002 Apr;6(2):105-10.

PMID:
19753733
48.

A novel protocol that allows short-term stem cell expansion of both committed and pluripotent hematopoietic progenitor cells suitable for clinical use.

Astori G, Malangone W, Adami V, Risso A, Dorotea L, Falasca E, Marini L, Spizzo R, Bigi L, Sala P, Tonutti E, Biffoni F, Rinaldi C, Del Frate G, Pittino M, Degrassi A.

Blood Cells Mol Dis. 2001 Jul-Aug;27(4):715-24; discussion 725-7.

PMID:
11778655
49.

Flow cytometric characterization of ex vivo expanded umbilical cord blood CD34(+) cells.

Malangone W, Belvedere O, Feruglio C, Spizzo R, Astori G, Adami V, Dorotea L, Falasca E, Sala PG, Tonutti E, Biffoni F, Rinaldi C, Del Frate G, De Anna D, Degrassi A.

Transplant Proc. 2001 Feb-Mar;33(1-2):1764-5. No abstract available.

PMID:
11267503
50.

Increased blood volume and CD34(+)CD38(-) progenitor cell recovery using a novel umbilical cord blood collection system.

Belvedere O, Feruglio C, Malangone W, Bonora ML, Minisini AM, Spizzo R, Donini A, Sala P, De Anna D, Hilbert DM, Degrassi A.

Stem Cells. 2000;18(4):245-51.

Supplemental Content

Loading ...
Support Center